AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

TURK İLAÇ VE SERUM SANAYİ A.Ş.

Notice of Dividend Amount Jun 30, 2021

8900_rns_2021-06-30_0f55d18e-b9e7-40b7-ba54-5be3560cfc06.html

Notice of Dividend Amount

Open in Viewer

Opens in native device viewer

Summary Info Turk İlaç ve Serum Sanayi A.Ş. 2020 Yılı Kar Dağıtımı Yönetim Kurulu Teklifi
Update Notification Flag Yes
Correction Notification Flag No
Postponed Notification Flag No
Decision Date 24.06.2021
Date of Related General Assembly 29.06.2021
Was The Issue of Dividend Payment Negotiated? Discussed
Type of Cash Dividend Payment Cash Dividend Will Not Be Paid
Currency Unit TRY
Stock Dividend Will Not Be Paid

Cash Dividend Payment Amount and Rates

Share Group Info Payment Cash Dividend To Be Paid For Share With Par Value of 1 TL - Gross (TL) Cash Dividend To Be Paid For Share With Par Value of 1 TL - Gross (%) Withholding Rate (%) Cash Dividend To Be Paid For Share With Par Value of 1 TL - Net (TL) Cash Dividend To Be Paid For Share With Par Value of 1 TL - Net (%)
A Grubu, İşlem Görmüyor, TRETRLC00014 0,0000000 0 0 0,0000000 0
B Grubu, TRILC, TRETRLC00022 0,0000000 0 0 0,0000000 0

Amount and Rate of Cash Dividend Stock Dividend Payment

Share Group Info Amount of Stock Dividend (TL) Rate of Stock Dividend (%)
A Grubu, İşlem Görmüyor, TRETRLC00014 0 0
B Grubu, TRILC, TRETRLC00022 0 0

Additional Explanations

Esas sözleşmemiz, Türk Ticaret Kanunu ve Sermaye Piyasası Kurulu düzenlemelerine uygun olarak 48.743,45 TL hesaplanan Genel Kanuni Yedek Akçe düşüldükten sonra 33.281.265,55 TL Net Dağıtılabilir Dönem Karına ulaşılmaktadır.

Vergi Usul Kanunu Hükümlerine (Yasal Kayıt) göre Net Dağıtılabilir Dönem Karı 926.125,55 TL dir.

VUK çerçevesinde hazırlanan 31.12.2020 tarihli finansal tablolarımızda oluşan geçmiş yıllar zararı nedeniyle kâr dağıtılmamasına ilişkin önerinin 2020 yılı Olağan Genel Kurulunda karara bağlanmak üzere teklif edilmesine karar verilmiştir.

Supplementary Documents

Appendix: 1 2020 Yılı Kar Dağıtım Tablosu.pdf

DIVIDEND DISTRIBUTION TABLE

TURK İLAÇ VE SERUM SANAYİ A.Ş. 01.01.2020/31.12.2020 Period Dividend Payment Table (TL)

1.Paid-In / Issued Capital 77.050.000
2. Total Legal Reserves (According to Legal Records) 34.527,37
Information on privileges in dividend distribution, if any, in the Articles of Association: Yoktur
* Based on CMB Regulations Based on Legal Records
3. Current Period Profit 40.260.706 5.006.937
4. Taxes Payable (-) 6.930.697 879.024
5. Net Current Period Profit 33.330.009 4.127.913
6. Losses in Previous Years (-) 3.945.394 3.153.044
7. Primary Legal Reserve (-) 48.743,45 48.743,45
8. Net Distributable Current Period Profit 33.281.265,55 926.125,55
Dividend Advance Distributed (-)
Dividend Advance Less Net Distributable Current Period Profit 33.281.265,55 926.125,55
9. Donations Made During The Year ( + )
10. Donation-Added Net Distributable Current Period Profit on which First Dividend Is Calculated 33.281.265,55 926.125,55
11. First Dividend to Shareholders
* Cash
* Stock
12. Dividend Distributed to Owners of Privileged Shares
13. Other Dividend Distributed
* To the Employees
* To the Members of the Board of Directors
* To Non-Shareholders
14. Dividend to Owners of Redeemed Shares
15. Second Dividend to Shareholders
16. Secondary Legal Reserves
17. Statutory Reserves
18. Special Reserves
19. Extraordinary Reserves 926.125,55 926.125,55
20. Other Distributable Resources

Dividend Rate Table Explanations

Talk to a Data Expert

Have a question? We'll get back to you promptly.